Evercore ISI Starts Carisma Therapeutics Inc (CARM) at Outperform
Tweet
Share
E-mailGet Alerts CARM Hot Sheet
Price: $0.15 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Evercore ISI analyst Liisa Bayko initiates coverage on Carisma Therapeutics Inc (NASDAQ: CARM) with a Outperform rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Carisma Therapeutics Inc click here. For more ratings news on Carisma Therapeutics Inc click here.
Shares of Carisma Therapeutics Inc closed at $8.89 yesterday.
You May Also Be Interested In
- Morgan Stanley Starts eMemory Technology Inc (3529:TT) at Overweight
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
